An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Clinical trial NCT07224373 · RECRUITING

Trial details

NCT number: NCT07224373
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2025-12-09
Primary completion: 2028-12-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.